Such is the link between the two disciplines, Marketer of the Year will celebrate its 25th anniversary at The Tower Hotel, London on Thursday 15 November, alongside the all-new Sales Awards. More: Celebrating sales and marketing excellence Source: News
read morePart of Allergan’s medical aesthetics strategy depends on securing follow-on indications for its CoolSculpting fat-freezing system, and the product recently came through with a new approval. More: Allergan works toward blockbuster goal with new jawline approval for CoolSculpting Source: fierce
read moreSeveral big drugmakers have posted big share price gains in the first nine months of the year, while other companies have seen only modest declines, according to a report from Vantage. More: Lilly, Merck and Pfizer lead pharma's share price
read moreOcrevus was already the most successful drug launch in Roche’s 122-year history, having hit blockbuster status this summer. Now Roche is rolling out new five-year data from a pivotal trial that could ratchet up the enthusiasm for the product—and sway
read moreA new analysis has shown that Novartis’ crizanlizumab reduced the number of patients with sickle cell disease experiencing a pain crisis. More: Novartis crizanlizumab shows promise in sickle cell anaemia Source: News
read moreShares in German biopharma Affimed dropped near 30% after the company said it was placing a key Phase I programme of its experimental cancer immunotherapy on hold because of serious side effects observed in trials, including a patient death. More:
read more© 1994 - 2026 B.M. Pharmaceuticals